SARS-CoV-2 Mpro-IN-56 is an orally active SARS-CoV-2 Mpro inhibitor with an IC50 of 0.026 µM. SARS-CoV-2 Mpro-IN-56 can be used for the research of COVID-19[1].
Molecular Weight:
620.69
Formula:
C34H22F2N4O2S2
Target:
SARS-CoV
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted